VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TVRD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TVRDTvardi Therapeutics, Inc.
$1.91$18M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTVRDQuarterly Balance Sheet

Tvardi Therapeutics, Inc. (TVRD) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Tvardi Therapeutics, Inc. (TVRD) quarterly balance sheet — complete assets, liabilities & equity history

TVRD Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23
Total Current Assets31.54M38.44M43.13M23.46M43.83M47.91M63.86M81.22M26.16M100.6M
Cash & Short-Term Investments30.81M36.46M40.99M22.31M37.9M43.54M56.62M69.77M22.92M78.95M
Cash Only20.73M21.42M20.65M11.44M37.9M38.56M49.24M47M22.92M63.28M
Short-Term Investments10.08M15.04M20.35M10.87M04.97M7.38M22.78M015.67M
Accounts Receivable00004.5M1.37M1.82M2.92M4.02M5.73M
Days Sales Outstanding-------147.86149.25429.81
Inventory0000900K625K1.64M2.74M03.27M
Days Inventory Outstanding------39.9K402.31-737.22
Other Current Assets01.98M000000-4.02M0
Total Non-Current Assets535K578K620K4.35M03.42M8.64M8.87M843K14.73M
Property, Plant & Equipment196K223K249K275K03.42M7.14M7.37M378K8.49M
Fixed Asset Turnover---9.34x---0.55x0.68x0.57x
Goodwill0000000000
Intangible Assets322K338K354K369K0000448K0
Long-Term Investments0000001.5M1.5M1.5M6.25M
Other Non-Current Assets17K17K17K3.71M0000-1.48M0
Total Assets32.07M39.02M43.75M27.81M43.83M51.33M72.5M90.1M27M115.34M
Asset Turnover---0.07x---0.04x0.04x0.04x
Asset Growth %-26.82%-23.98%-39.65%-69.14%62.32%-55.5%----
Total Current Liabilities11.04M11.04M10.68M7M3.97M10.04M13.9M15.1M3.28M22.88M
Accounts Payable3.22M4.08M2.42M1.69M1.43M2.54M6.75M4.98M1.61M7.98M
Days Payables Outstanding--3.98K---106.77K483.55639.271.8K
Short-Term Debt000003.42M168K220K0497K
Deferred Revenue (Current)0000000000
Other Current Liabilities1.3M1.01M7.4M01.97M2.91M5.76M7.83M942K9.04M
Current Ratio2.86x3.48x4.04x3.35x11.03x4.77x4.59x5.38x7.97x4.40x
Quick Ratio2.86x3.48x4.04x3.35x10.81x4.71x4.48x5.20x7.97x4.25x
Cash Conversion Cycle-------66.62--633.82
Total Non-Current Liabilities85K115K145K35.93M44.45M40.58M47M45.2M85.78M6.82M
Long-Term Debt00035.76M44.45M40.58M39.68M38.38M00
Capital Lease Obligations85K115K145K174K007.32M6.83M275K6.82M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities0000000085.5M0
Total Liabilities11.13M11.15M10.82M42.93M48.42M50.62M60.9M60.3M89.06M29.7M
Total Debt201K228K254K36.04M44.45M44M47.16M45.42M368K7.31M
Net Debt-20.53M-21.19M-20.39M24.6M6.54M5.44M-2.08M-1.57M-22.55M-55.97M
Debt / Equity0.01x0.01x0.01x--62.23x4.07x1.52x-0.09x
Debt / EBITDA----------
Net Debt / EBITDA----------
Interest Coverage----0.71x-3.85x-1.81x-3.65x-14.49x--
Total Equity20.95M27.87M32.93M-15.12M-4.59M707K11.6M29.8M-62.06M85.64M
Equity Growth %556.04%3841.44%183.9%-150.74%92.6%-99.17%----
Book Value per Share2.232.973.89-1.62-3.010.467.633.19-6.6356.85
Total Shareholders' Equity20.95M27.87M32.93M-15.12M-4.59M707K11.6M29.8M-62.06M85.64M
Common Stock9K9K9K19K5K54K54K54K19K54K
Retained Earnings-110.45M-103.17M-97.65M-101.81M-755.61M-747.93M-735.46M-715.44M-62.84M-652.41M
Treasury Stock0000000000
Accumulated OCI8K7K-13K2K0-25K-121K-191K0-439K
Minority Interest0000000000